Skip to main content
SpringerLink
Log in

Panvax febrile convulsion rate “acceptable” in Australia

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Australian Government, Australian Technical Advisory Group on Immunisation (ATAGI), Therapeutic Good Administration (TGA) Joint Working Group.Analysis of febrile convulsions following immunisation in children following monovalent pandemic H1N1 vaccine (Panvax Rm/Panvax Junior Rm, CSL). Internet Document: [2 pages], 28 Sep 2010. Available from: URL: http://www.tga.gov.au

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Panvax febrile convulsion rate “acceptable” in Australia. React. Wkly. 1323, 3 (2010). https://doi.org/10.2165/00128415-201013230-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013230-00006

Keywords

Search

Navigation